Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Pharmaceutics|June 27, 2024
Correction: Shrewsbury, S.B. The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and "Nose-to-Brain". Pharmaceutics 2023, 15, 1720Stephen B ShrewsburyPharmaceutical Medicine|August 3, 2023
The Pharmacokinetics of Drugs Delivered to the Upper Nasal SpaceStephen B ShrewsburyPain Management|March 18, 2026
DHE - past, present, and future: a narrative reviewStephen B ShrewsburyPharmaceutics|June 28, 2023
The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and "Nose-to-Brain"Stephen B ShrewsburyInternational Journal of Toxicology|January 30, 2010
Safety pharmacology and genotoxicity evaluation of AVI-4658Peter Sazani, Doreen L Weller, Stephen B ShrewsburyHeadache|November 19, 2019
Dihydroergotamine (DHE) - Then and Now: A Narrative ReviewStephen D Silberstein, Stephen B Shrewsbury, John HoekmanInternational Journal of Pharmaceutics|September 13, 2008
Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthmaStephen B Shrewsbury, Andrew P Bosco, Paul S UsterHeadache|September 16, 2009
Reduced adverse event profile of orally inhaled DHE (MAP0004) vs IV DHE: potential mechanismRobert O Cook, Stephen B Shrewsbury, Nabih M RamadanJournal of Clinical Medicine|July 2, 2021
Nasal Delivery of Acute Medications for Migraine: The Upper Versus Lower Nasal SpaceVincent Martin, John Hoekman, Sheena K Aurora, et al.International Journal of Pharmaceutics|February 22, 2008
Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionateStephen B Shrewsbury, Thomas A Armer, Stephen P Newman, et al.Pageof 3